Precision BioSciences (DTIL) Stock Forecast, Price Target & Predictions
DTIL Stock Forecast
Precision BioSciences stock forecast is as follows: an average price target of $15.50 (represents a 86.97% upside from DTIL’s last price of $8.29) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
DTIL Price Target
DTIL Analyst Ratings
Precision BioSciences Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Apr 01, 2024 | Justin Zelin | BTIG | $30.00 | $13.56 | 121.24% | 261.88% |
Nov 10, 2022 | - | Goldman Sachs | $1.00 | $1.38 | -27.54% | -87.94% |
Precision BioSciences Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $30.00 |
Last Closing Price | $8.29 | $8.29 | $8.29 |
Upside/Downside | -100.00% | -100.00% | 261.88% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
May 16, 2024 | Guggenheim | Underperform | Underperform | Hold |
May 16, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Apr 01, 2024 | BTIG | Buy | Buy | Hold |
Jun 17, 2022 | BMO Capital | - | Outperform | Initialise |
Precision BioSciences Financial Forecast
Precision BioSciences Revenue Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | $13.12M | $19.79M | $8.78M | $10.60M | $7.36M | $3.82M | $3.32M | $6.34M | $24.04M | $68.81M | $16.35M | $8.85M | $7.36M | $1.08M | $7.00M | $6.52M | $4.87M | $5.39M | $5.46M |
Avg Forecast | $11.00M | $11.00M | $13.70M | $10.00M | $6.61M | $5.33M | $7.70M | $5.34M | $12.47M | $8.99M | $6.38M | $5.67M | $6.81M | $9.86M | $4.97M | $7.73M | $9.04M | $6.02M | $13.86M | $8.30M | $5.93M | $4.34M | $5.09M | $4.14M | $8.74M | $6.21M | $8.00M | $5.55M |
High Forecast | $11.00M | $11.00M | $13.70M | $10.00M | $6.61M | $5.33M | $7.70M | $5.34M | $12.47M | $9.19M | $6.38M | $5.67M | $6.81M | $9.86M | $4.97M | $7.73M | $9.04M | $6.02M | $13.86M | $8.30M | $5.93M | $4.34M | $5.09M | $4.14M | $8.74M | $6.21M | $8.00M | $5.55M |
Low Forecast | $11.00M | $11.00M | $13.70M | $10.00M | $6.61M | $5.33M | $7.70M | $5.34M | $12.47M | $8.79M | $6.38M | $5.67M | $6.81M | $9.86M | $4.97M | $7.73M | $9.04M | $6.02M | $13.86M | $8.30M | $5.93M | $4.34M | $5.09M | $4.14M | $8.74M | $6.21M | $8.00M | $5.55M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Surprise % | - | - | - | - | - | - | - | - | - | 1.46% | 3.10% | 1.55% | 1.56% | 0.75% | 0.77% | 0.43% | 0.70% | 3.99% | 4.96% | 1.97% | 1.49% | 1.69% | 0.21% | 1.69% | 0.75% | 0.78% | 0.67% | 0.98% |
Precision BioSciences EBITDA Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EBITDA | - | - | - | - | - | - | - | - | - | $-11.53M | $-11.89M | $-23.76M | $-16.01M | $-21.29M | $-28.63M | $-25.87M | $-19.74M | $-8.65M | $24.34M | $-16.22M | $-20.98M | $-23.52M | $-30.25M | $-24.45M | $-19.11M | $-19.34M | $-18.27M | $-30.66M |
Avg Forecast | $-8.75M | $-8.75M | $-10.90M | $-7.96M | $-5.26M | $-4.24M | $-6.12M | $-4.25M | $-9.92M | $-7.15M | $-5.07M | $-4.51M | $-5.41M | $-7.84M | $-3.96M | $-29.70M | $-7.19M | $-4.79M | $-11.02M | $-21.74M | $-4.72M | $-3.46M | $-4.05M | $-24.45M | $-6.95M | $-4.94M | $-6.37M | $-85.62M |
High Forecast | $-8.75M | $-8.75M | $-10.90M | $-7.96M | $-5.26M | $-4.24M | $-6.12M | $-4.25M | $-9.92M | $-7.00M | $-5.07M | $-4.51M | $-5.41M | $-7.84M | $-3.96M | $-23.76M | $-7.19M | $-4.79M | $-11.02M | $-17.39M | $-4.72M | $-3.46M | $-4.05M | $-19.56M | $-6.95M | $-4.94M | $-6.37M | $-68.49M |
Low Forecast | $-8.75M | $-8.75M | $-10.90M | $-7.96M | $-5.26M | $-4.24M | $-6.12M | $-4.25M | $-9.92M | $-7.31M | $-5.07M | $-4.51M | $-5.41M | $-7.84M | $-3.96M | $-35.64M | $-7.19M | $-4.79M | $-11.02M | $-26.09M | $-4.72M | $-3.46M | $-4.05M | $-29.34M | $-6.95M | $-4.94M | $-6.37M | $-102.74M |
Surprise % | - | - | - | - | - | - | - | - | - | 1.61% | 2.34% | 5.26% | 2.96% | 2.72% | 7.24% | 0.87% | 2.75% | 1.81% | -2.21% | 0.75% | 4.45% | 6.80% | 7.47% | 1.00% | 2.75% | 3.92% | 2.87% | 0.36% |
Precision BioSciences Net Income Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Net Income | - | - | - | - | - | - | - | - | - | $-8.08M | $-11.89M | $-23.56M | $-36.49M | $-24.96M | $-32.47M | $-28.99M | $-22.34M | $-11.28M | $21.66M | $-18.69M | $-23.45M | $-26.02M | $-32.70M | $-26.84M | $-20.92M | $-20.74M | $-19.44M | $-31.78M |
Avg Forecast | $-1.82M | $-2.31M | $-490.81K | $-2.73M | $-11.74M | $-14.98M | $-14.88M | $-16.61M | $-14.36M | $-38.39M | $-51.33M | $-47.54M | $-42.60M | $-70.12M | $-91.71M | $-32.34M | $-99.58M | $-124.51M | $-93.51M | $-25.04M | $-105.47M | $-138.30M | $-124.41M | $-26.84M | $-103.37M | $-105.88M | $-80.98M | $-88.75M |
High Forecast | $-1.82M | $-2.31M | $-490.81K | $-2.73M | $-11.74M | $-14.98M | $-14.88M | $-16.61M | $-14.36M | $-38.39M | $-51.33M | $-47.54M | $-42.60M | $-70.12M | $-91.71M | $-25.87M | $-99.58M | $-124.51M | $-93.51M | $-20.03M | $-105.47M | $-138.30M | $-124.41M | $-21.47M | $-103.37M | $-105.88M | $-80.98M | $-71.00M |
Low Forecast | $-1.82M | $-2.31M | $-490.81K | $-2.73M | $-11.74M | $-14.98M | $-14.88M | $-16.61M | $-14.36M | $-38.39M | $-51.33M | $-47.54M | $-42.60M | $-70.12M | $-91.71M | $-38.81M | $-99.58M | $-124.51M | $-93.51M | $-30.05M | $-105.47M | $-138.30M | $-124.41M | $-32.20M | $-103.37M | $-105.88M | $-80.98M | $-106.50M |
Surprise % | - | - | - | - | - | - | - | - | - | 0.21% | 0.23% | 0.50% | 0.86% | 0.36% | 0.35% | 0.90% | 0.22% | 0.09% | -0.23% | 0.75% | 0.22% | 0.19% | 0.26% | 1.00% | 0.20% | 0.20% | 0.24% | 0.36% |
Precision BioSciences SG&A Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
SG&A | - | - | - | - | - | - | - | - | - | $9.63M | $9.83M | $11.09M | $10.07M | $10.33M | $10.48M | $10.69M | $10.62M | $9.64M | $9.94M | $9.50M | $9.20M | $8.53M | $8.70M | $9.62M | $8.48M | $7.05M | $6.50M | $5.00M |
Avg Forecast | $11.91M | $11.91M | $14.83M | $10.83M | $7.15M | $5.78M | $8.33M | $5.78M | $13.50M | $9.74M | $6.90M | $6.14M | $7.37M | $10.67M | $5.38M | $8.37M | $9.79M | $6.52M | $15.00M | $8.99M | $6.42M | $4.70M | $5.51M | $4.49M | $9.46M | $6.72M | $8.66M | $6.01M |
High Forecast | $11.91M | $11.91M | $14.83M | $10.83M | $7.15M | $5.78M | $8.33M | $5.78M | $13.50M | $9.95M | $6.90M | $6.14M | $7.37M | $10.67M | $5.38M | $8.37M | $9.79M | $6.52M | $15.00M | $8.99M | $6.42M | $4.70M | $5.51M | $4.49M | $9.46M | $6.72M | $8.66M | $6.01M |
Low Forecast | $11.91M | $11.91M | $14.83M | $10.83M | $7.15M | $5.78M | $8.33M | $5.78M | $13.50M | $9.52M | $6.90M | $6.14M | $7.37M | $10.67M | $5.38M | $8.37M | $9.79M | $6.52M | $15.00M | $8.99M | $6.42M | $4.70M | $5.51M | $4.49M | $9.46M | $6.72M | $8.66M | $6.01M |
Surprise % | - | - | - | - | - | - | - | - | - | 0.99% | 1.42% | 1.80% | 1.37% | 0.97% | 1.95% | 1.28% | 1.09% | 1.48% | 0.66% | 1.06% | 1.43% | 1.81% | 1.58% | 2.14% | 0.90% | 1.05% | 0.75% | 0.83% |
Precision BioSciences EPS Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EPS | - | - | - | - | - | - | - | - | - | $-0.07 | $-0.00 | $-0.21 | $-0.33 | $-0.23 | $-0.48 | $-0.47 | $-0.37 | $-0.19 | $0.38 | $-0.33 | $-0.45 | $-0.50 | $-0.63 | $-0.52 | $-0.41 | $-0.41 | $-0.39 | $-1.99 |
Avg Forecast | $-0.26 | $-0.33 | $-0.07 | $-0.39 | $-1.68 | $-2.14 | $-2.12 | $-2.37 | $-2.05 | $-5.47 | $-7.32 | $-6.78 | $-6.08 | $-10.00 | $-13.08 | $-16.23 | $-14.20 | $-17.76 | $-13.34 | $-14.90 | $-15.04 | $-19.73 | $-17.74 | $-15.53 | $-14.74 | $-15.10 | $-11.55 | $-11.72 |
High Forecast | $-0.26 | $-0.33 | $-0.07 | $-0.39 | $-1.68 | $-2.14 | $-2.12 | $-2.37 | $-2.05 | $-5.47 | $-7.32 | $-6.78 | $-6.08 | $-10.00 | $-13.08 | $-16.23 | $-14.20 | $-17.76 | $-13.34 | $-14.90 | $-15.04 | $-19.73 | $-17.74 | $-15.53 | $-14.74 | $-15.10 | $-11.55 | $-11.72 |
Low Forecast | $-0.26 | $-0.33 | $-0.07 | $-0.39 | $-1.68 | $-2.14 | $-2.12 | $-2.37 | $-2.05 | $-5.47 | $-7.32 | $-6.78 | $-6.08 | $-10.00 | $-13.08 | $-16.23 | $-14.20 | $-17.76 | $-13.34 | $-14.90 | $-15.04 | $-19.73 | $-17.74 | $-15.53 | $-14.74 | $-15.10 | $-11.55 | $-11.72 |
Surprise % | - | - | - | - | - | - | - | - | - | 0.01% | 0.00% | 0.03% | 0.05% | 0.02% | 0.04% | 0.03% | 0.03% | 0.01% | -0.03% | 0.02% | 0.03% | 0.03% | 0.04% | 0.03% | 0.03% | 0.03% | 0.03% | 0.17% |
Precision BioSciences Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
PASG | Passage Bio | $0.60 | $6.00 | 900.00% | Buy |
XFOR | X4 Pharmaceuticals | $0.53 | $3.67 | 592.45% | Buy |
BDTX | Black Diamond Therapeutics | $2.99 | $14.75 | 393.31% | Buy |
INZY | Inozyme Pharma | $4.42 | $14.67 | 231.90% | Buy |
PLRX | Pliant Therapeutics | $14.49 | $39.71 | 174.05% | Buy |
DAWN | Day One Biopharmaceuticals | $14.81 | $38.80 | 161.99% | Buy |
ABOS | Acumen Pharmaceuticals | $2.95 | $7.00 | 137.29% | Buy |
STOK | Stoke Therapeutics | $13.10 | $30.60 | 133.59% | Buy |
TERN | Terns Pharmaceuticals | $7.10 | $14.25 | 100.70% | Buy |
DTIL | Precision BioSciences | $8.29 | $15.50 | 86.97% | Buy |
MREO | Mereo BioPharma Group | $4.01 | $6.75 | 68.33% | Buy |
CYTK | Cytokinetics | $51.48 | $83.23 | 61.67% | Buy |
DYN | Dyne Therapeutics | $28.78 | $43.88 | 52.47% | Buy |
RVMD | Revolution Medicines, Inc. Warrant | $55.87 | $58.57 | 4.83% | Buy |
HOOK | HOOKIPA Pharma | $3.76 | $3.00 | -20.21% | Buy |
DTIL Forecast FAQ
Is Precision BioSciences a good buy?
Yes, according to 3 Wall Street analysts, Precision BioSciences (DTIL) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of DTIL's total ratings.
What is DTIL's price target?
Precision BioSciences (DTIL) average price target is $15.5 with a range of $1 to $30, implying a 86.97% from its last price of $8.29. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Precision BioSciences stock go up soon?
According to Wall Street analysts' prediction for DTIL stock, the company can go up by 86.97% (from the last price of $8.29 to the average price target of $15.5), up by 261.88% based on the highest stock price target, and down by -87.94% based on the lowest stock price target.
Can Precision BioSciences stock reach $12?
DTIL's average twelve months analyst stock price target of $15.5 supports the claim that Precision BioSciences can reach $12 in the near future.
What are Precision BioSciences's analysts' financial forecasts?
Precision BioSciences's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $24.98M (high $24.98M, low $24.98M), average EBITDA is $-19.869M (high $-19.869M, low $-19.869M), average net income is $-58.208M (high $-58.208M, low $-58.208M), average SG&A $27.04M (high $27.04M, low $27.04M), and average EPS is $-8.302 (high $-8.302, low $-8.302). DTIL's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $45.7M (high $45.7M, low $45.7M), average EBITDA is $-36.355M (high $-36.355M, low $-36.355M), average net income is $-7.362M (high $-7.362M, low $-7.362M), average SG&A $49.48M (high $49.48M, low $49.48M), and average EPS is $-1.05 (high $-1.05, low $-1.05).
Did the DTIL's actual financial results beat the analysts' financial forecasts?
Based on Precision BioSciences's last annual report (Dec 2023), the company's revenue was $48.73M, beating the average analysts forecast of $33.51M by 45.40%. Apple's EBITDA was $-42.527M, beating the average prediction of $-26.66M by 59.52%. The company's net income was $-61.319M, missing the average estimation of $-152M by -59.55%. Apple's SG&A was $39.09M, beating the average forecast of $36.28M by 7.73%. Lastly, the company's EPS was $-0.016, missing the average prediction of $-21.622 by -99.93%. In terms of the last quarterly report (Sep 2023), Precision BioSciences's revenue was $13.12M, beating the average analysts' forecast of $8.99M by 45.88%. The company's EBITDA was $-11.532M, beating the average prediction of $-7.155M by 61.18%. Precision BioSciences's net income was $-8.079M, missing the average estimation of $-38.389M by -78.95%. The company's SG&A was $9.63M, missing the average forecast of $9.74M by -1.07%. Lastly, the company's EPS was $-0.0701, missing the average prediction of $-5.475 by -98.72%